Overview

Global Intravitreal Injectables Market Introduction:
The global intravitreal (IVT) injectables market is poised to value over USD 5 billion by 2029 end. 


Intravitreal (IVT) injectables are immensely prevalent among eye specialists. Anti–vascular endothelial growth factor (anti-VEGF) drugs are primarily used for treating macular degeneration, retinal vein occlusion, diabetic retinopathy and others. Rising prevalence of these diseases has expanded the anti-VEGF market assisting the growth of global IVT market.

Global Intravitreal Injectables Market Overview:
Based on drug class, the market is fragmented into anti-VEGF, antibiotics, corticosteroids, antifungals and antivirals. Corticosteroids are primarily used for treating knee osteoarthritis, for reducing disease-induced inflammation, asthma, allergies, etc. However this is acstrong medicine and can cause weight gain, fragile bones, glaucoma, thinning of the skin and many more such side effects which hamper the market growth of this segment.

Based on the type of indication, the market is bifurcated into diabetic retinopathy, macular degeneration, Endophthalmitis and retinal vein occlusions. Patients suffering from diabetes mellitus are more prone to get diabetic retinopathy and the diabetes mellitus patient pool is mainly found in the Asia Pacific region, India and China in particular. Therefore, this market segment has huge potential for its expansion in not only the Asia Pacific region but in the entire world. 

Distribution-wise, the market is categorised as hospital pharmacies, retail pharmacies, drug stores and mail order pharmacies.

Global Intravitreal Injectables Market Regional Insight:
The global IVT injectables market is regionally bifurcated into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. North American region have shown high market growth owing to the high prevalence of blindness and low vision in the region and frequent prescription of anti-VEGF IVT injectables has propelled the market growth.


Global Intravitreal Injectables Market Segmentation:
1.    By Region

•    North America
•    Europe
•    Asia Pacific
•    Middle East & Africa
•    Latin America

2.    By Drug Class
•    Anti-VEGF
•    Antibiotics
•    Corticosteroids
•    Antifungals
•    Antivirals

3.    By Indication
•    Diabetic Retinopathy
•    Macular Degeneration
•    Endophthalmitis
•    Retinal Vein Occlusions

4.    By Distribution
•    Hospital Pharmacies
•    Retail Pharmacies
•    Drug Stores
•    Mail order Pharmacies

Competitive Landscape:
•    Bausch & Lomb
•    Novartis AG
•    Allergan
•    F. Hoffmann-La Roche Ltd.
•    Thrombogenics Inc.
•    Alimera Sciences

FutureWise Key Takeaways:
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study:
•    To provide with an exhaustive analysis on the global Intravitreal injectables market by region, by drug class, by indication, by distribution
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Middle East & Africa and Latin America
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies 

 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics